Table: Santen Pharm -2024/25 parent results

SANTEN PHARMACEUTICAL

13/05/2025 07:33

May 13 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            188.10          195.24                                
                 (-3.7 pct)      (-0.7 pct)                              
  Operating         23.41           28.01                                
                 (-16.4 pct)     (+13.0 pct)                             
  Recurring         26.23           31.27                                
                 (-16.1 pct)     (+15.5 pct)                             
  Net               17.80           18.68                                
                 (-4.7 pct)                                              
  EPS             51.03 yen       50.88 yen                              
  EPS Diluted     50.89 yen       50.74 yen                              
  Ann Div         36.00 yen       33.00 yen      38.00 yen               
  -Q2 Div         17.00 yen       16.00 yen      19.00 yen               
  -Q4 Div         19.00 yen       17.00 yen      19.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T